Trial intelligence / Profile preview

Lycopene Gel vs Minocycline Microspheres in Periodontal Treatment

NCT03964935Phase 2Unknown

Sponsor
University of Baghdad
Start
Dec 2018
Primary completion
Aug 2019
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of lycopene in chronic periodontitis (3 arms), sponsored by University of Baghdad. Primary endpoints: Level of inflammatory markers MMP-9, TGF-Beta 1, IL-8, TIMP-1 in gingival crevicular fluid at 14 days, Clinical Attachment Level at 14 days and 1 more. Status: unknown.

02

Drugs

lycopene
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT03964935.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03964935.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call